Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/07/2008CA2676167A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
08/07/2008CA2676163A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity
08/07/2008CA2676160A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives
08/07/2008CA2676138A1 Compounds and compositions as kinase inhibitors
08/07/2008CA2676129A1 Methods of modulating immune function
08/07/2008CA2675677A1 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors
08/07/2008CA2675510A1 Method for decreasing inflammation and oxidative stress in mammals
08/07/2008CA2675471A1 Chromene s1p1 receptor antagonist
08/07/2008CA2675468A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008CA2675466A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/07/2008CA2675450A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders
08/07/2008CA2675378A1 Chitosan-based colloidal particles for rna delivery
08/07/2008CA2675348A1 Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
08/07/2008CA2675221A1 Novel 2-aminooxazolines as taar1 ligands
08/07/2008CA2675148A1 Use of catecholamines and related compounds as anti-angiogenic agents
08/07/2008CA2674913A1 Punctal plugs and methods of delivering therapeutic agents
08/07/2008CA2673734A1 Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
08/07/2008CA2673465A1 Method for decreasing inflammation and stress in a mammal
08/07/2008CA2672808A1 Process for the preparation of o-desmethyl venlafaxine
08/07/2008CA2669563A1 Agent for treatment of multiple sclerosis
08/06/2008EP1953243A2 Polynucleotides related to colon cancer
08/06/2008EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same
08/06/2008EP1953171A1 Aminoglycoside antibiotics targeting bacterial 16S ribosomal RNA
08/06/2008EP1953170A1 Monosaccharide derivatives as anti-inflammatory agents
08/06/2008EP1953165A1 Aza-substituted spiro derivative
08/06/2008EP1953164A1 Therapeutic or prophylactic agent for functional bowel disorder
08/06/2008EP1953163A1 Pteridinone derivatives as PI3-kinases inhibitors
08/06/2008EP1953162A1 Xanthin derivatives, their production and utilisation as medicine
08/06/2008EP1953161A1 New tricyclic derivatives, method of preparing same and pharmaceutical compositions containing them
08/06/2008EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/06/2008EP1953159A1 6-Benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds useful as PDE5 inhibitors
08/06/2008EP1953158A1 Bicyclic cinnamide compound
08/06/2008EP1953157A1 New crystal form of cabergoline
08/06/2008EP1953154A1 Morpholine type cinnamide compound
08/06/2008EP1953153A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1953151A1 Salts of cynnamide compound or solvates thereof
08/06/2008EP1953148A1 Heterocyclic amide compound and use thereof
08/06/2008EP1953147A1 Heterocyclic compound and medicinal application thereof
08/06/2008EP1953145A1 Heterocyclic compound having inhibitory activity on 11- -hydroxysteroid dehydrogenase type i
08/06/2008EP1953144A1 Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
08/06/2008EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
08/06/2008EP1953141A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
08/06/2008EP1953140A1 Process for the preparation of ezetimibe and derivatives thereof
08/06/2008EP1953138A2 Fenicol compounds and methods of synthesizing 2-trifluoracetamido-3-substituted propiophenone compounds
08/06/2008EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
08/06/2008EP1952828A2 Hemostatic textile material
08/06/2008EP1952824A1 Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
08/06/2008EP1952819A2 Method for preventing gastritis using amylin or amylin agonists
08/06/2008EP1952817A1 Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia
08/06/2008EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient
08/06/2008EP1952813A1 Medicament for the treatment of endometriosis
08/06/2008EP1952812A1 Drug for treating thalessemia, falciform anemia and all other forms of anemia treatable therewith
08/06/2008EP1952811A1 The use of eriocalyxin b in the manufacture of medicaments for treating leukemia
08/06/2008EP1952810A1 Treatment of breast cancer with 4-hydroxytamoxifen
08/06/2008EP1952809A2 Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen
08/06/2008EP1952808A2 Composition in the form of a spray comprising calcitriol
08/06/2008EP1952807A1 Sirolimus formulation
08/06/2008EP1952806A1 Process for the preparation of adsorbates of candesartan
08/06/2008EP1952805A1 Tablet containing hydrogenated phospholipids
08/06/2008EP1952803A1 Solid pharmaceutical dosage form containing hydrogenated phospholipids
08/06/2008EP1952802A2 Buccal, polar and non-polar spray or capsule
08/06/2008EP1952700A1 Method of improving absorption of vitamin E by a pet animal
08/06/2008EP1952695A1 Oil bodies and method of producing such oil bodies
08/06/2008EP1952293A2 Methods for the identification of microrna and their applications in research and human health
08/06/2008EP1951891A1 Cancer antigen mage-a9 and uses thereof
08/06/2008EP1951872A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
08/06/2008EP1951740A2 High affinity siglec ligands
08/06/2008EP1951739A1 An improved process for the isolation of arjunic acid from the bark of the tree terminalia arjuna and the use of this compound in the treatment of cancer
08/06/2008EP1951738A2 Further crystalline forms of rostafuroxin
08/06/2008EP1951737A2 Rnai inhibition of influenza virus replication
08/06/2008EP1951735A1 New 4*-substituted erythromycin derivative
08/06/2008EP1951731A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/06/2008EP1951730A1 Heteroalkyl linked pyrimidine derivatives
08/06/2008EP1951729A1 Oxygen linked pyrimidine derivatives
08/06/2008EP1951728A2 Thienopyridine b-raf kinase inhibitors
08/06/2008EP1951727A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
08/06/2008EP1951725A1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases
08/06/2008EP1951724A2 FUSED BICYCLIC mTOR INHIBITORS
08/06/2008EP1951722A1 A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4-inhibitor and a method of preparing same
08/06/2008EP1951721A1 3 -monosubstituted tropane derivatives as nociceptin receptor ligands
08/06/2008EP1951720A1 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1]octane-3-carboxylic acid amide as ligand for the nociceptin receptor orl-1
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1951718A1 4-oxadiazolyl-piperidine compounds and use thereof
08/06/2008EP1951717A1 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
08/06/2008EP1951716A1 Aminopyrimidines useful as kinase inhibitors
08/06/2008EP1951715A2 Aminopyrimidines useful as kinase inhibitors
08/06/2008EP1951712A2 Chemical compounds
08/06/2008EP1951711A1 Indole derivatives as antitumoural compounds
08/06/2008EP1951708A2 Piperazine derivatives useful as ccr5 antagonists
08/06/2008EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase
08/06/2008EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase
08/06/2008EP1951705A1 Novel antifungal triazole derivatives
08/06/2008EP1951704A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
08/06/2008EP1951703A2 Desloratadine crystalline forms mixtures having a low level of residual solvents
08/06/2008EP1951702A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders
08/06/2008EP1951701A2 Ep2 receptor agonists
08/06/2008EP1951698A1 Iap bir domain binding compounds
08/06/2008EP1951697A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines
08/06/2008EP1951696A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/06/2008EP1951693A2 Solid formulations
1 ... 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 ... 7860